PharmaMar and Eczasibasi sign a licensing agreement for Aplidin® in Turkey

(Pharmamar) PharmaMar (MSE:PHM) has announced today a licensing agreement with Eczasibasi Group to commercialize the marine-derived anticancer drug Aplidin® (plitidepsin) in Turkey.

Comments